Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Regulatory T cells (Tregs) are a specialized subpopulation of CD4+ T lymphocytes that play a central role in maintaining immune homeostasis and self-tolerance. They actively suppress the activation and proliferation of other immune cells, thereby preventing autoimmune diseases, moderating chronic inflammation, and limiting excessive immune responses to pathogens or environmental insults. Tregs employ multiple mechanisms to modulate immune responses, including secretion of inhibitory cytokines, induction of apoptosis, cell-to-cell contact inhibition, and metabolic disruption. Understanding how to modulate regulatory T cell function has significant translational potential for treating autoimmunity, cancer, and other diseases.
Tregs employ multiple mechanisms to modulate immune responses including secretion of inhibitory cytokines (IL-10, TGF-β, IL-35), induction of apoptosis in effector immune cells (Granzyme B), cell-to-cell contact inhibition (CTLA‐4, TIGIT, LAG3), induction of immunosuppressive enzymes in dendritic cells (IDO), and generation of adenosine via CD39/CD73 pathway.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immune modulation via regulatory T cell.